Revvity Launches Cloud-Native Molecular Cloning Platform Signals BioDesign
Revvity, Inc. has debuted Signals BioDesign, a new cloud-native molecular cloning platform. The tool aims to streamline biologics research and development by managing up to 1,000 constructs within a…











